SAN FRANCISCO & PRINCETON, N.J.–(BUSINESS WIRE)–Kardigan, a heart health company modernizing cardiovascular drug development, launched today with a mission to develop multiple targeted treatments in parallel, bringing people with cardiovascular diseases closer to the cures they deserve. “For decades, our team has observed significant treatment gaps across cardiovascular disease – from clinical care to investment in new medicines. While current standards of care play an important role, collect
Go to Source
Author: